Loading clinical trials...
Loading clinical trials...
A Phase II Study of Gemcitabine in Combination With Capecitabine in Advanced Cholangiocarcinoma
Conditions
Interventions
capecitabine
gemcitabine hydrochloride
Locations
1
United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
October 1, 2002
Primary Completion Date
May 1, 2004
Completion Date
November 1, 2006
Last Updated
January 12, 2012
NCT07146646
NCT06123117
NCT05404347
NCT05833815
NCT07310069
NCT05564403
Lead Sponsor
Roswell Park Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions